Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| TFX | TELEFLEX INC | 2026-05-19 14:59:54 | 132.79 | 2.22 | 1.7 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 0000096943 | TELEFLEX INC | US8793691069 | UUL85LWXB4NGSWWXIQ25 | 231147939 | NYSE | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 550 E SWEDESFORD RD | WAYNE | PA | 19087 | UNITED STATES | US | 610-225-6800 | 550 E SWEDESFORD RD, WAYNE, PA, 19087 | 550 E SWEDESFORD RD, WAYNE, PA, 19087 | — | — | 1943 | Liam J. Kelly | 15,000 | http://teleflex.com | 2,297,660,795 | 48,197,000 | 44,270,211 | Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) is Liam J. Kelly; Kelly is also the company's president and former chief operating officer. | 2026-05-14 16:14:53 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 2,297,660,795 | -1,980,526,403 | -46.2936 | 44,200,562 | -2,165,901 | -4.6713 |
| 2024 | 4,278,187,198 | -1,355,903,129 | -24.0661 | 46,366,463 | -690,019 | -1.4664 |
| 2023 | 5,634,090,327 | -1,356,471,787 | -19.4043 | 47,056,482 | 112,327 | 0.2393 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James P. Winters | Corporate Vice President | 2025 | 529,040 | 137,033 | 372,997 | 58,838 | 87,683 | 1,722,410 |
| John R. Deren | Executive Vice President | 2025 | 548,916 | 144,590 | 526,442 | 59,972 | 71,122 | 2,111,783 |
| Liam J. Kelly | Chief Executive Officer, President | 2025 | 1,144,400 | 143,050 | 2,005,604 | 227,280 | 325,566 | 6,732,419 |
| Cameron P. Hicks | Corporate Vice President | 2025 | 436,300 | 110,541 | 279,728 | 48,524 | 68,677 | 1,346,374 |
| Daniel V. Logue | Secretary, Corporate Vice President, General Counsel | 2025 | 453,375 | 131,736 | 372,997 | 50,423 | 59,354 | 1,604,846 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 15,500 |
| 2024 | 14,100 |
| 2023 | 14,500 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 1,992,713,000 | 3,047,324,000 | 2,974,489,000 |
| Cost Of Revenue | 871,959,000 | 1,344,645,000 | 1,327,558,000 |
| Gross Profit | 1,120,754,000 | 1,702,679,000 | 1,646,931,000 |
| Research And Development Expenses | 144,781,000 | 161,672,000 | 154,351,000 |
| General And Administrative Expenses | 720,169,000 | 995,271,000 | 929,867,000 |
| Operating Expenses | 1,002,381,000 | 1,551,666,000 | 1,140,618,000 |
| Operating Income | 118,373,000 | 151,013,000 | 506,313,000 |
| Net Income | -905,640,000 | 69,675,000 | 356,328,000 |
| Earnings Per Share Basic | -20.3 | 1.49 | 7.58 |
| Earnings Per Share Diluted | -20.25 | 1.48 | 7.53 |
| Weighted Average Shares Outstanding Basic | 44,622,000 | 46,837,000 | 46,981,000 |
| Weighted Average Shares Outstanding Diluted | 44,724,000 | 47,094,000 | 47,304,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 378,564,000 | 290,188,000 | 222,848,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 345,583,000 | 459,495,000 | 443,467,000 |
| Inventories | 404,395,000 | 600,133,000 | 626,216,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 150,678,000 | 117,851,000 | 107,471,000 |
| Total Assets Current | 1,938,338,000 | 1,471,124,000 | 1,407,406,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 498,281,000 | 502,852,000 | 479,913,000 |
| Other Assets Non Current | 112,984,000 | 102,624,000 | 98,943,000 |
| Total Assets Non Current | 5,008,901,000 | 5,626,790,000 | 6,125,140,000 |
| Total Assets | 6,947,239,000 | 7,097,914,000 | 7,532,546,000 |
| Accounts Payable | 130,201,000 | 141,031,000 | 132,247,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 100,000,000 | 100,000,000 | 87,500,000 |
| Other Liabilities Current | 137,195,000 | 67,243,000 | 46,547,000 |
| Total Liabilities Current | 762,026,000 | 649,360,000 | 606,745,000 |
| Long Term Debt | 2,641,449,000 | 1,655,871,000 | 1,815,072,000 |
| Other Liabilities Non Current | 194,532,000 | 102,307,000 | 162,502,000 |
| Total Liabilities Non Current | 3,060,445,000 | 2,170,414,000 | 2,484,813,000 |
| Total Liabilities | 3,822,471,000 | 2,819,774,000 | 3,091,558,000 |
| Common Stock | 48,197,000 | 48,096,000 | 48,046,000 |
| Retained Earnings | 3,149,760,000 | 4,115,870,000 | 4,109,736,000 |
| Accumulated Other Comprehensive Income | -239,468,000 | -316,669,000 | -314,405,000 |
| Total Shareholders Equity | 3,124,768,000 | 4,278,140,000 | 4,440,988,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 177,738,000 | 274,601,000 | 242,118,000 |
| Share Based Compensation Expense | 25,695,000 | 31,348,000 | 31,465,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 85,533,000 | 27,952,000 | 15,763,000 |
| Change In Inventories | -84,041,000 | -1,925,000 | 41,068,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 35,585,000 | -43,026,000 | 11,420,000 |
| Change In Accounts Payable | -8,284,000 | 9,665,000 | -31,258,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 96,682,000 | 638,260,000 | 511,683,000 |
| Purchases Of Marketable Securities | 5,000,000 | 7,300,000 | 11,300,000 |
| Sales Of Marketable Securities | 0 | 7,300,000 | 7,300,000 |
| Acquisition Of Property Plant And Equipment | 95,236,000 | 126,434,000 | 91,442,000 |
| Acquisition Of Business | 16,500,000 | — | 10,600,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -36,538,000 | 0 | 0 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 60,470,000 | 63,541,000 | 63,896,000 |
| Issuance Of Common Stock | 37,175,000 | 34,029,000 | 37,146,000 |
| Repurchase Of Common Stock | 303,044,000 | 201,895,000 | — |
| Issuance Of Long Term Debt | 1,140,000,000 | 130,000,000 | 646,000,000 |
| Repayment Of Long Term Debt | 153,000,000 | 291,500,000 | 544,750,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 611,539,000 | -421,925,000 | 38,540,000 |
| Change In Cash | 126,199,000 | 104,802,000 | -69,186,000 |
| Cash At End Of Period | 378,564,000 | 290,188,000 | 222,848,000 |
| Income Taxes Paid | 117,658,000 | 164,902,000 | 114,211,000 |
| Interest Paid | 119,337,000 | 98,376,000 | 100,218,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -20.3 | 1.49 | 7.58 |
| Price To Earnings Ratio | -6.0118 | 119.4497 | 32.8945 |
| Earnings Growth Rate | -1,462.4161 | -80.343 | -2.0672 |
| Price Earnings To Growth Ratio | 0.0041 | -1.4867 | -15.9127 |
| Book Value Per Share | 70.0275 | 91.341 | 94.5273 |
| Price To Book Ratio | 1.7427 | 1.9485 | 2.6378 |
| Ebitda | -510,021,000 | 592,722,000 | 797,739,000 |
| Enterprise Value | 7,808,553,880 | 9,801,732,260 | 13,393,966,540 |
| Dividend Yield | 0.0111 | 0.0076 | 0.0055 |
| Dividend Payout Ratio | -0.0668 | 0.912 | 0.1793 |
| Debt To Equity Ratio | 0.8773 | 0.4104 | 0.4284 |
| Capital Expenditures | 173,167,000 | 297,540,000 | 274,826,000 |
| Free Cash Flow | -76,485,000 | 340,720,000 | 236,857,000 |
| Return On Equity | -0.2898 | 0.0163 | 0.0802 |
| One Year Beta | 0.7513 | 0.6414 | 1.0487 |
| Three Year Beta | 0.7961 | 0.8761 | 0.9311 |
| Five Year Beta | 0.8512 | 0.9421 | 0.9618 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Patil Neena M | Director | 2026-05-15 | 1,090 | A | 3,716 |
| Patil Neena M | Director | 2026-05-15 | 2,397 | A | 2,397 |
| TOKICH MICHAEL J | Director | 2026-05-15 | 1,090 | A | 1,090 |
| TOKICH MICHAEL J | Director | 2026-05-15 | 4,793 | A | 4,793 |
| Duncan Candace H | Director | 2026-05-15 | 1,090 | A | 7,039 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Susan M Collins | Senator | 2014-12-01 | Purchase | 2014-11-10 | Spouse | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lisa McClain | 2025-08-13 | MI09 | Sale | 2025-07-22 | Spouse | $1,001 - $15,000 |
| Lisa McClain | 2025-08-13 | MI09 | Purchase | 2025-07-16 | Spouse | $1,001 - $15,000 |
| Rob Bresnahan | 2025-03-27 | PA08 | Sale | 2025-02-25 | — | $1,001 - $15,000 |
| Daniel Goldman | 2023-08-13 | NY10 | Sale | 2023-07-12 | — | $15,001 - $50,000 |
| Daniel Goldman | 2023-05-19 | NY10 | Purchase | 2023-04-10 | — | $15,001 - $50,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Western Wealth Management, LLC | 2026-03-31 | 488 | 4 | 122 |
| CIM INVESTMENT MANAGEMENT INC | 2026-03-31 | 519,945 | 4,347 | 119.6101 |
| Edgestream Partners, L.P. | 2026-03-31 | 251,540 | 2,103 | 119.6101 |
| JANUS HENDERSON GROUP PLC | 2026-03-31 | 513,281,224 | 4,291,311 | 119.6094 |
| South Dakota Investment Council | 2026-03-31 | 1,499,000 | 12,530 | 119.6329 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RUSSELL INVESTMENT FUNDS | 2026-03-31 | U.S. Small Cap Equity Fund | RIFBX | 757 | 90,544.77 | 0.0435 |
| Russell Investments Exchange Traded Funds | 2026-03-31 | Russell Investments U.S. Small Cap Equity ETF | RUSC | 825 | 98,678.25 | 0.1999 |
| Series Portfolios Trust | 2026-03-31 | Institutional Class | PVCIX | 22,215 | 2,657,136.15 | 1.1994 |
| Series Portfolios Trust | 2026-03-31 | Investor Class | PVCMX | 22,215 | 2,657,136.15 | 1.1994 |
| Mercer Funds | 2026-03-31 | Class Y-3 | MSCGX | 31,614 | 3,781,350.54 | 0.2205 |